Nasdaq Biotechnology Index rises 3.2% after Moderna and Merck’s melanoma vaccine achieves success in large-scale trials.
智通财经2026/08/19 13:46Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
The Nasdaq Biotechnology Index rose 3.2% after Moderna and Merck & Co's melanoma vaccine achieved success in a large-scale trial.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
